Pharmacoeconomic analysis of biological treatments for psoriatic arthritis
Psoriatic arthritis is an inflammatory and possibly destructive form of arthritis; left untreated, psoriatic arthritis can be a progressively disabling disease. The arthritic manifestations often include debilitating disease of the hands and feet, as well as painful inflammation of the tendon insert...
Main Authors: | Mario Eandi, Carlo Salvarani |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2006-09-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/263 |
Similar Items
-
Current views on the pharmacotherapy of psoriatic arthritis
by: G. G. Taradin, et al.
Published: (2016-01-01) -
MANAGEMENT OF A PATIENT WITH SEVERE COURSE OF PSORIATIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2013-05-01) -
Analysis and evaluation of the cost of the treatment anti-TNFα in rheumatoid arthritis and ankylosing spondylitis. Individualised front marketed dose
by: Félix Gómez-De Rueda, et al.
Published: (2017-06-01) -
Equivalence and switching between biosimilars and reference molecules in rheumatoid arthritis: protocol for a systematic review and meta-analysis
by: Bruna O. Ascef, et al.
Published: (2021-07-01) -
Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)